Our portfolio

We focus on the transfer of new technologies into practice. We were established by the Institute of Organic Chemistry and Biochemistry of the CAS and are dedicated to innovations in the field of drug development, diagnostics and medical devices originating from academic institutions. We support the creation of spin-off companies and the sale of licenses. So far, we have participated in the creation or otherwise supported 15 spin-off companies from 5 countries, have an equity stake in 9 of them and have invested over 70 million crowns. Overall, the spin-offs in i&i Prague's portfolio have raised more than CZK 1.8 billion from other investors.